Hyperinsulinemia and insulin resistance in hypertension: Differential effects of antihypertensive agents

Clinical and Experimental Hypertension

Volumn 21, Issue 1-2, 1999, Pages 167-179

  Goyal, Ramesh K ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

ACE inhibitors; Antihypertensives; Calcium channel blockers; Diabetes mellitus; Hypertension; Insulin resistance

Indexed keywords

AMLODIPINE; ENALAPRIL; LISINOPRIL; NIFEDIPINE; NITRENDIPINE; PERINDOPRIL; RAMIPRIL; SPIRAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES;

EID: 0033013063     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909068659     Document Type: Conference Paper

References (44)

1. Stamler, J., Wentworth, D., Vaccaro, O., Neaton, J.D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care, 1993; 16: 434-444.
2. Reaven, G.M. Role of insulin resistance in human disease. Banting Lecture. Diabetes, 1988; 37: 1595-1607.
3. Rosenstok, J., Raskin, P. Early diabetic nephropathy assessment and potential interventions. Diabetes Care, 1986; 9: 529-531.
4. Knowler, W.C., Bennett, P.H., Ballintine, E.J. Increased incidence of retinopathy in diabetics with elevated blood pressure. N. Engl J Med, 1980; 302: 645-647.
5. MacMohan, S., Peto, R., Cutler, J., Collins, R., Sorthe, P., et al. Blood pressure, stroke and coronary heart disease. Lancet, 1990; 335: 765-774.
6. Zatz, R., Dunn, B.R., Meyer, T.W. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986; 77: 1925-1930.
7. Kuller, L.H., Dorman, J.S., Wolf, P.A. Cerebrovascular disease and diabetes. In: Diabetes in America (85-468): US Dept of Health and Human Services, 1985; 1-18.
8. Fuh, MM-T, Sheith, S-M, Wu, D.A., Chen, I., Reaven, G.M. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med. 1987; 147: 1035-1038.
9. Kannel, W.B. Lipids, diabetes and coronary heart disease: Insight from the Framingham Study. Am Heart J., 1985; 110: 1100-1107.
10. Rodrigues, B., Goyal, R.K., McNeill, J.H. Effects of hydralazine on STZ induced diabetic rats - prevention of hyperlipidaemia and improvement in cardiac function. J Pharmac Expt Ther 1986; 237: 299-307.
11. Goyal R.K., Bangaru, R.A., Lakkad, N.B., Rao, M.V. Effect of chronic treatment with atenolol and prazosin in streptozotocin induced diabetic rats. Ind J Physiol Pharmacol. 1996; 40(3): 220-224.
12. Goyal, R.K., Lakkad, N.B., Rao, M.V. Effects of chronic treatment with enalapril on streptozotocin-induced diabetic rats. Pharmacol Rev Comm. 1997, 9: 133-139.
13. Shah, T.S., Satia, M.C., Gandhi, T.P., Bangaru, R.A., Goyal, R.K. Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol. 1995; 26: 6-12.
14. Damani, R.C., Satia, M.C., Goyal, R.K. Beneficial effects of clonidine in streptozotocin induced diabetes and DOCA hypertensive rats. J Pharm Pharmacol 1997; 49: 1030-1035.
15. Bangaru, R.A., Lakkad, N.B., Goyal, R.K. Effect of chronic atenolol treatment on diabetes induced cardiac depression and other complications. Ind J Physiol Pharmacol. 1996; 40: 220-224.
16. Joshi, S.S., Shah, T.S., Goyal, R.K. Effects of chronic treatment with nitrendipine in streptozotocin-induced diabetic rats. Ind J Pharm Sci. 1996; 58(3): 100-105.
17. Hakim, Z.S., Patel, B.K., Goyal, R.K. Effects of chronic ramipril treatment in streptozotocin-induced diabetic rats. Ind J Physiol Pharmacol 1997; 41(4): 353-360.
18. Kawashima, H. Chronic hypertension induced by ITZ in rats. Naunyn Schiemedberg Arch Pharmacol. 1978; 305: 123-126.
19. 2 in rats with STZ induced diabetes. Naunyn Schimedbergs Arch Pharmacol. 1983; 322: 290-294.
20. Funakawa, S. Renin angiotensin system and prostacyclin biosynthesis in STZ diabetic rats. Eur J Pharmacol. 1983; 94: 27-33.
21. Kusaka, M., Kishi, K., Sokabe, H. Does so-called streptozotocin hypertension exists in rats? Hypertens 1987; 10: 517-521.
22. Hebden, R.A., Todd, M.E., Tnag, C., Gowen, B., McNeill, J.H. Association of DOCA hypertension with induction of atherosclerosis in rats with short-term diabetes-mellitus. Am J Physiol. 1990; 251: F563-F575.
23. Sevak, A.R., Goyal, R.K. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin-induced diabetic and DOCA hypertensive rats. Pharm Res 1996; 34: 210-209.
24. Dia, S., McNeill, J.H. Myocardial performance of streptozotocin diabetic and DOCA-hypertensive rats. Am J Physiol. 1992; 263:H1798-H1805.
25. Collins, W.C.J., Cullen, M.J., Feely. J. Calcium channel blocker drugs and diabetic control. Clin Pharmacol Pher. 1987; 42: 420-423.
26. Tebtorio, A., Ghilardi, G., Pedroncelli, A., Benco, R., Stroppa, S., et al. Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment. Eur J Clin Pharmacol. 1989; 36: 311-313.
27. Reaven, G.M. Insulin resistance, hyperinsulinemia and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med. 1991; 907S-12S.
28. Christensen, C.K., Krussad, L.R., Mongensen, C.E. Increased blood pressure in diabetes: Essential hypertension or diabetic nephropathy? Sand J Clin Lab Invest 1987; 47: 363-370.
29. DeFronzo, R.A., Cooke, C.R., Andres, R., Falona, G.R., Davis, P.J. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate, in man. J Clin Invest. 1975; 55: 845-855.
30. Cruz, A.B., Amatuzio, D.S., Grande, F., Hay, L.J. Effect of intra arterial insulin on tissue cholesterol and fatty acids in alloxan diabetic dogs. Circ Res 1961; 9: 39-43.
31. Pfeifle, B., Ditschuneit, H. Effect of insulin on the growth of cultured arterial smooth muscle cells. Diabetologia 1981; 20: 155-158.
32. Hulman, S., Falkner, B., Chen, Y.Q. Insulin resistance in the spontaneously hypertensive rat. Metabolism 1991; 40: 359-361.
33. Cadihac, M., Guidicelli, J.F. Myocardial and vascular effects of perindopril, a new converting enzyme inhibitor, during hypertension development in SHR. Arch Inter de Pharmacodyn et de ther 1986; 284: 116-126.
34. Christensen, K.L., Jerpersen, L.T., Mulvany, M.J. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long term treatment related to vascular structure. J Hypertens. 1989; 7: 83-90.
35. Buchanan, T.Z., Sipos, G.F., Madrilejo, N., Chaplin, L., Campese, V.M. Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol. 1992; 262: E14-E19.
36. Frontoni, S., Ohman, L., Haywood, J.R., De Fronzo, R.A., Rossetti, L. In vivo insulin action in genetic models of hypertension. Am J Physiol. 1992; 262: E191-E196.
37. Srinivasan, P.S., Hakim, Z.S., Santani, D.D., Goyal, R.K. Effect of chronic treatment with amlodipine in streptozotocin-diabetic and spontaneously hypertensive rats. Pharm Res 1997; 31(1): 1-6.
38. Parulekar, A.A., Srinivasan, P.S., Hakim, Z.S., Santani, D.D., Goyal, R.K. Spirapril attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Ind J Hypertens. 1996; 1:8-10.
39. Shenoy, A.G., Reddy, C.K., Santani, D.D., Goyal, R.K. Effects of chronic treatment with perindopril on insulin sensitivity and cardiovascular parameters in spontaneously hypertensive and streptozotocin-diabetic rats. Pharmacol Res 1998 (in press).
40. Mehta, A.A., Patel, S., Santani, D.D., Goyal, R.K. Effect of nifedipine and enalapril on insulin-induced glucose disposal in spontaneously hypertensive and diabetic rats. Clin Exp Hypertens. 1998; (in press).
41. Weir, G.C., Clore, E.T. Islet secretion in a new experimental model of NIDDM. Diabetes 1981; 30: 590-595.
42. Gokhale, M.S., Shah, D.H., Hakim, Z.S., Santani, D.D., Goyal, R.K. Effects of chronic treatment with amlodipine in non-insulin dependent diabetic rats. Pharm Res. In press.
43. Satia, M.C., Shukla, M.L., Gandhi, T.P., Goyal, R.K. Prevalence of hypertension and comparative evaluation of four antihypertensives monotherapy in Indian NIDDM hypertensive patients. Ind J Hypertens 1997; 2: 17-27.
44. Satia, M.C., Shukla, M.L., Goyal, R.K. Effects of enalapril on lipid profile in diabetic and non-diabetic essential hypertensive patients. Ind J Physiol Pharmacol. 1996; 40: 83-86.